載入...
Steering CAR T cells to distinguish friend from foe
CD19-specific chimeric antigen receptor (CAR)(+) T cells have demonstrated clinical efficacy and long-lasting remissions, concomitant with tolerable normal B-cell aplasia. However, many tumor-associated antigens (TAAs) are expressed on normal tissues, the destruction of which would lead to intolerab...
Na minha lista:
| 發表在: | Oncoimmunology |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Taylor & Francis
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6791456/ https://ncbi.nlm.nih.gov/pubmed/31646067 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2016.1271857 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|